Q4 2017

Filed Mar 9, 2018 · 10-K · 68 days after period end · 0001723128-18-000005

Q4 2017 · 10-K

Revenue

$293.37M

no prior Q4 2016 on file

Net Income

$0.00

no prior Q4 2016 on file

EPS Diluted

$0.00

no prior Q4 2016 on file

Gross Profit$151,416,000—

Operating Cash Flow

Same quarter

no prior Q4 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2017 · filed Mar 9, 2018 · 68 d after period end

Amneal Pharmaceuticals, Inc. · CIK 1723128 · Engraved from SEC EDGAR